Medical Discovery Clinical Research LLC is categorized under Medical Research in Montgomery, AL and active since 2009.
Medical Discovery Clinical Research LLC was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Gloria Rudolph Burnett at the company’s single location by writing to 300 Taylor Road # 900, Montgomery, Alabama AL 36117 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Medical Discovery Clinical Research LLC |
Contact Person: | Gloria Rudolph Burnett |
Address: | 300 Taylor Road # 900, Montgomery, Alabama 36117 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2009 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
Medical Discovery Clinical Research LLC was started in 2009 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Gloria Rudolph Burnett for inquiries that concern Medical Discovery Clinical Research LLC by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Medical Discovery Clinical Research LLC can be found at the coordinates 32.377719,-86.173029 as well as the street address 300 Taylor Road # 900 in Montgomery, Alabama 36117.
For its online presence, you may visit Medical Discovery Clinical Research LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.